Author: CannabisNewsWire (CNW)

About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces Launch of JustCBD Products on Amazon.co.uk

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, today announced that its wholly-owned subsidiary JustCBD will be launching its line of Novel Foods-registered CBD products on Amazon.co.uk. Since its entry into the now £700 million CBD market in October 2021, Amazon U.K. has expanded the initial pilot-only program to include vendors who have demonstrated compliance with U.K. CBD Novel Food regulations. Producers awarded U.K. Novel Food authorization must prove the product is safe for consumption and labeled correctly. “With health and wellness playing an increasingly important role in customers’ lives, we are excited to increase the selection of quality CBD products offered to Amazon customers in the U.K.,” said Hussein Rakine, CEO of JustCBD. “The JustCBD team looks forward to working closely with Amazon to expand our product offering to other countries as our partnership and brand presence in the United Kingdom grows.”

To view the full press release, visit https://cnw.fm/gtGhR

About Flora Growth Corp.

Flora is building a connected, design-led collective of plant-based wellness and lifestyle brands delivering the most compelling customer experiences in the world, one community at a time. As the operator of one of the most extensive outdoor cannabis cultivation facilities, Flora leverages natural, cost-effective cultivation practices to supply cannabis derivatives to its commercial, house of brands and life sciences divisions. Visit www.FloraGrowth.com or follow @floragrowthcorp on social media for more information.

NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://cnw.fm/FLGC

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CWCBExpo, the Premier B2B Cannabis, and Hemp Expo and Conference to Foster Lively Discussion on Industry Opportunities and Challenges Among Seasoned Professionals and Newcomers Alike

The Cannabis World Congress & Business Exposition (CWCBExpo) will be held between June 2-4, 2022, at the Javits Convention Center, Hall 3A, in New York City. Industry heavyweights, the foremost innovators, and pioneering thought leaders will take the stage to discuss emerging trends in cannabis, hemp, and allied sectors. The expo will provide a high-quality business-focused attendee base located in the premier East Coast US cannabis and hemp market. 

The three-day event will feature an Inside the Industry: Thought Leadership Series in an interactive “Talk Show” format. Co-hosts will include Carl Cameron, veteran journalist and former FOX News reporter; Faye Coleman, Founder and CEO of Pure Genesis, cannabis pioneer and entrepreneur Calvin Frye, and Gretchen Gailey, Chief Strategist at CWCBExpo. The Thought Leadership series will address distinct aspects of the sector each day. Day 1, Thursday, will focus on Investing and Industry Progress, Day 2 will address Policy and Legislation, and Day 3 will explore new developments in Cannabis and Lifestyle. The sessions will be educational and relevant to both the local landscape and the national outlook. 

The conference program will also feature two keynote conversations with Chris Beals, CEO of Weedmaps, along with Mona Zhang, States Cannabis Policy Reporter, POLITICO, on Thursday, Jun 2; and with Nick Kovacevich, CEO of Greenlane Holdings, along with Tim Seymour, Co-host, CNBC Fast Money.

In addition to the wide array of expert speakers and eminent business people in attendance, the summit will host hundreds of exhibitors showcasing cutting-edge product innovations and the latest services. 

The event shall also host a Networking Mixer on Thursday, June 2, from 5 – 7 pm, sponsored by Weedmaps, so that attendees can network or relax ahead of the second day of the conference.

On Friday, June 3, from 6 – 10 pm, CWCBExpo will host the Industry Yacht Party, where attendees can eat, drink and dance with their peers while savoring the majestic New York City skyline. This is a premier networking and deal-making opportunity.

To attend either or both events, registered attendees must purchase a Networking Mixer Ticket or an Industry Yacht Party Ticket. Get your tickets now at the best price! Why wait?

Cannabis Week, anchored by CWCBExpo, will take place from Monday, May 30 to Sunday, June 5, 2022, and will foster collaboration between the entire cannabis industry through industry deep dives, networking events, and lead-generation opportunities.  Several events will take place during the week throughout New York City. 

To learn more about Cannabis Week, event itineraries, available offers, and discounts, visit  https://cwcbexpo.com/cannabis-week

For more information about the CWCBExpo, please visit https://cwcbexpo.com/

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Pollen Study in Spain Reveals Thriving Illegal Cannabis Grows

A study exploring the concentration of marijuana pollen in the atmosphere in the Spanish city of Murcia has discovered that levels of pollen are increasing in the atmosphere. This is a clear indication that the extent of illicit cannabis farming is trending upwards.

For decades, scientists have been documenting the amount of marijuana pollen present in the air in order to estimate the extent of illegal marijuana cultivation taking place in different cities, including Cartagena, Lorca and Murcia. This trio of cities is of special interest because they are located along the seashore acting as a border between Spain and Morocco.

The researchers were intrigued to discover that, after analyzing the collected pollen, only a small fraction of the pollen could be traced to North Africa. This means that the vast majority of the illicit grows were on Spanish soil and that the country was becoming increasingly less dependent on imported cannabis. Rather, it was now depending on a domestically produced crop to meet the local needs and the needs of the other foreign markets in need of this illicit marijuana.

It was also found that both Lorca and Cartagena were far ahead in the concentration of marijuana pollen detected in the atmosphere. This duo registered in excess of 80 pollen grains in each cubic meter of air. In contrast, Murcia’s illegal grows peaked back in 2020 when the city recorded 66 pollen grains for each cubic meter of air measured.

For comparison purposes, the three Spanish cities logged pollen readings in the range of 19-27 grains per cubic meter back in 2017. This shows that the increase in illegal cultivation activity has been massive over the past few years.

Previously, people only thought of the marijuana clubs around Barcelona when discussions about cannabis use arose. However, the authorities and policymakers are just waking up to the reality that cannabis cultivation and use is widespread across the entire nation.

Consequently, the country is scrambling to find ways to regulate a sector where consumers and their suppliers are ahead of the government. Last year, the country initiated steps to permit the use of marijuana for medicinal purposes. The authorities have also granted four licenses to companies  to grow and manufacture pharmaceutical-grade cannabis products. These are exclusively for export.

Strict cannabis laws notwithstanding, Spanish products ranging from CBD products to marijuana products have been found throughout the continent, which explains why recent months have seen widely publicized busts of large illegal marijuana grows. If the country eventually creates a regulated market for marijuana allowing local and international marijuana companies such as Flora Growth Corp. (NASDAQ: FLGC) to operate, scientists will no longer have to analyze pollen collections in order to get an idea about cannabis use.

NOTE TO INVESTORS: The latest news and updates relating to Flora Growth Corp. (NASDAQ: FLGC) are available in the company’s newsroom at https://cnw.fm/FLGC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Franchising Offers Exciting Possibilities for Marijuana Industry

In November 2020, residents in New Jersey voted to legalize marijuana in the state. The next year, Gov. Phil Murphy signed three legislations on the legalization of cannabis. In April of this year, recreational retail stores in the state opened their doors to the public, making New Jersey the 14th state to legalize and implement the sale of recreational cannabis and decrease the penalties for underage use.

The commission in the state gave approval to a more than 100 conditional licenses for smaller growers and manufacturers. Despite having approval, it may take a year or longer for these operations to begin selling their products.

Franchising may make it easier for those involved in the space to navigate the system with the right product, training and services. Below are a number of ways through which franchising can be good for those involved in the industry not just in New Jersey but across the country.

Better compliance

Many dispensaries in different parts of the country have had to close shop because of infractions. Franchises usually have compliance teams that ensure that your business is up-to-date on regulation.

No supply chain issues

Cannabis plants can’t be transported across state lines because of federal regulations. This means that growers in most states will have to start from square one, which is time consuming.

Franchise systems are focused on obtaining and providing products quickly as well as ensuring the best pricing for the product. They also create standards across every franchise location regardless of the state and ensure quality, which eliminates any obvious issues that may impact the supply chain.

Good marketing strategies

Creating consistency and brand awareness is a top objective for marijuana franchisors. With a franchise, consumers have the same level of quality products and same experience at every location, which helps market a brand well.

Good site location

Franchise systems help businesses identify the best locations for a marijuana enterprise that can bring in a plenty of solid traffic while also complying with local zoning codes.

Conduct training

Marijuana franchises help ensure that a business and its team undergo extensive training to guarantee that the best customer services are provided, along with high-quality products.

At the moment, however, marijuana businesses are primarily still cash businesses as the federal legalization of cannabis is yet to be approved. This is a big issue, especially when one considers that marijuana franchises don’t qualify for small business administration loans, which may make it hard for cannabis companies, such as Cannabis Strategic Ventures Inc. (OTC: NUGS), to look to franchising as a good way to navigate the burgeoning industry.

NOTE TO INVESTORS: The latest news and updates relating to Cannabis Strategic Ventures Inc. (OTC: NUGS) are available in the company’s newsroom at http://cnw.fm/NUGS

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Leveraging DehydraTECH(TM) as It Looks to Tap into Various Markets

Lexaria Bioscience Corp. (NASDAQ: LEXX) has been pushing the boundaries of drug delivery through its patented DehydraTECH(TM) technology, which has evidenced more efficient delivery of active pharmaceutical ingredients (“APIs”) into the bloodstream while also increasing their bioavailability. “Its technology has seen application in pharmaceuticals, nutraceuticals, consumer packaged goods, and over-the-counter capsules, pills, tablets, and oral suspensions. Lexaria has explored its usage in the delivery of cannabinoids, nicotine, antivirals, PDE5 inhibitors, and more,” a recent article reads. “All of Lexaria’s efforts serve to demonstrate the superior performance of both its research program and its DehydraTECH drug delivery technology. By doing so, it is looking to tap into various markets, including but not limited to oral cannabinoids, oral mucosal nicotine, antivirals, human hormones, dementia, rheumatoid disease, and diabetes. Lexaria’s management hopes that, before the end of the 2022 calendar year, it will have built sufficient data to effect meaningful industry progress and sustainable increases in valuation to steer the conversation forward and allow for the greater adoption of DehydraTECH.”

To view the full article, visit https://cnw.fm/ZbMED

About Lexaria Bioscience Corp.

Lexaria’s patented drug delivery technology, DehydraTECH(TM), improves the way active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery. Since 2016, DehydraTECH has repeatedly demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by up to 5-10x, reduce time of onset from 1 – 2 hours to minutes, and mask unwanted tastes; and is also being evaluated for orally administered anti-viral drugs, non-steroidal anti-inflammatory drugs (“NSAIDs”), PDE5 inhibitors and more. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 25 patents granted and over 50 patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Lift&Co. Expo Toronto Showcased Innovations Powering Future of the Cannabis Sector

Lift&Co. Expo, Canada’s no. 1 cannabis conference and trade show, hosted its latest event on May 12-15, 2022, at the Metro Toronto Convention Centre. The Lift Cannabis Business Conference (May 12) and Lift&Co. Expo in the Centre’s North Hall (May 13-15) featured leading-edge content and exhibitors from across North America to showcase information and innovations powering the future of the cannabis industry. Event sessions included Next Gen Cannabis Innovations, New Big Product Categories and Cannabis Market Trends & Predictions. The expo also shined the spotlight on additional forward-thinking programming across both the cannabis and psychedelics sectors and covered engaging topics such as Athletes & Cannabis, Cannabis Crystal Ball, New Psychedelics Data and The Future of Edibles. “We are continually inspired by Lift&Co. Expo, but this year was especially significant,” said Shawn Pierce, president of the expo’s producer, MCI Events. “As the cannabis landscape defines its ‘new normal’ in the pandemic era, we’re proud to cultivate a welcoming space for creating connections and reinvigorating the industry.”

To view the full press release, visit https://cnw.fm/CE373

About Lift&Co. Expo

Launched in 2016, Lift&Co. Expo is the original large-scale cannabis trade show in Canada, serving the cannabis community as both a meeting place and a destination for discovery. Each Lift&Co. Expo showcases leading-edge content and premiere exhibitors in a festival-like setting for thousands of cannabis industry retailers, producers, growers, investors and decision-makers. Lift&Co. Expo is proudly produced by MCI Events. Visit https://LiftExpo.ca for more information.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Lexaria Bioscience Corp. (NASDAQ: LEXX) Leveraging Growing Commercial Opportunities

  • Lexaria is a biotechnology company focused on licensing its proprietary DehydraTECH(TM) technology
  • The DehydraTECH technology has been proven to increase the bioavailability, speed of onset and brain absorption of APIs, and improve customer experiences by masking unwanted tastes
  • Lexaria has 25 patents granted worldwide and is pursuing numerous other pending patent applications
  • The company operates several subsidiary companies to focus on different commercial opportunities 

Ever since acquiring its first intellectual property (“IP”) that subsequently formed the basis of its first two patent application filings in 2014, biotechnology company Lexaria Bioscience (NASDAQ: LEXX) has grown the number of patents granted and patent applications exponentially, with 25 patents granted worldwide as of April 2022. The latest patent, the 10th granted in the United States, represents the first-ever patent for the use of DehydraTECH(TM) drug delivery technology in the enhanced delivery of antiviral drugs. Described by CEO Chris Bunka as “another validation of the versatility of our DehydraTECH drug technology,” the award of the IP protection marks a key step toward the ultimate monetization of DehydraTECH, according to an April 21 news release (https://cnw.fm/q8zmr).

This monetization, Lexaria’s annual report (Form 10-K filing) for the fiscal year ended August 2021 notes (https://cnw.fm/bCzFD), will be realized through the company’s focus on R&D and subsequent strategic partnerships with licensees. 

“Lexaria’s formulation and process-oriented operations are primarily conducted in its own laboratory and validated through third-party testing in preparation for partnering with industry leaders for adoption into their consumer products and/or drugs. Other than for R&D purposes, Lexaria does not produce, manufacture, market, or distribute drugs,” the filing reads. “Our business plan is currently focused on the development of strategic partnerships with licensees for our patented DehydraTECH technology in exchange for upfront and/or staged licensing fees and/or royalty payments over time.”

This focus has been influenced by numerous learnings through the years, some of which have involved experimentation with consumer product development that included brewed tea, coffee, protein bars, candies, drink mixes and several other product types. Discoveries made through innovative formulation work drives Lexaria’s technology and licensing strategies. 

According to the company’s most recent quarterly report for the three months ended February 28, 2022 (https://cnw.fm/dkWiT), Lexaria operates wholly owned subsidiaries focused on commercial opportunities which include –Lexaria Hemp Corp. focused on primarily US-based business-to-business (“B2B”) CBD opportunities;  Lexaria Pharmaceutical Corp., focused on registered drug development and advancement;  – and Lexaria Nicotine LLC., owned 16.67% by giant tobacco company Altria, which is focused on oral nicotine development as an alternative to combusted or vaped nicotine (https://cnw.fm/yVd9h).

Lexaria Pharmaceutical Corp. is investigating the potential for new registered drug products for hypertension, anti-viral treatments, epilepsy, some pharmaceutical applications of nicotine and other drug classes. This is where the largest long-term value creators for the Company are developed. Lexaria CanPharm Corp. operates a state-of-the-art Health Canada-licensed laboratory capable of developing novel cannabinoid and many other types of formulations for potential commercialization. Much of Lexaria’s most secret development work is carried out in that laboratory by trusted scientists employed by the Company. 

These subsidiaries sublicense DehydraTECH in their respective business sectors for the delivery of fat-soluble molecules and drugs to other companies which is Lexaria’s central plan to generate highly profitable revenue streams over long periods. Additionally, Lexaria will continue pursuing its pending patent applications to further bolster shareholder value. In addition, the company “will continue to seek beneficial acquisitions of intellectual property” if and when it believes it is advisable to do so.

Lexaria is a drug delivery company focused on developing and licensing its proprietary DehydraTECH technology for improved delivery and rapidity of bioactive compounds in orally delivered and topical products, as well as enhanced customer experiences by masking unwanted tastes. The DehydraTECH technology has been proven to enhance the bioavailability of a broad range of fat-soluble active pharmaceutical ingredients (“APIs”), thereby improving the way they enter the bloodstream, lowering dosing, and facilitating healthier oral ingestion methods. 

For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.

420 with CNW — State Regulators Say Cannabis Banking Reform Will Ease Their Jobs

Last week, members of the Cannabis Regulators Association (CANNRA) penned a letter to leaders of congress. The letter’s primary signatories were regulators serving in Washington, Oregon, Nevada, Minnesota, Michigan, Hawaii and Georgia.

In the letter, the nonpartisan association outlined primary aspects of worry for the respective cannabis markets in their states. While it didn’t endorse the SAFE Banking Act directly, the letter did highlight that the absence of safe financial and banking services for marijuana industry actors and for the individuals involved in marijuana marketplaces was a public safety matter.

Legislators are currently holding a debate to attach the language of the SAFE Banking Act to the America COMPETES Act.

The letter stated that nearly all territories and member states of the association had been negatively affected by the lack of banking and financial services for marijuana businesses and those who worked with the marijuana industry. The primary issues the association identified concerned public security and safety, the need for small as well as minority-owned companies to have access to financial institutions and the lack of access to depository and banking services.

This banking issue has compelled many cannabis businesses into operating on cash-only terms, which makes them targets of criminal activity and threatens the public safety of communities and neighborhoods across the country.

In the letter, the association cited instances of recent robberies and violent crimes that took place at retail outlets in various states these last few months. The association noted that access to conventional banking services will strengthen efforts to prevent criminal enterprises and diversion and offer regulatory agencies better insight into legitimate operators.

The letter also highlighted that this issue was impacting small plus minority-owned businesses. The letter explained that while big businesses had the capability to identify and then use alternatives for financial transactions, small businesses struggled with this and were often left to operate on cash-only terms with no access to capital, which in turn affected their viability as well as success in the legal cannabis space.

CANNRA noted in the letter that this grew the already unequal playing field, which existed for small as well as minority-owned marijuana businesses.

Additionally, absence of access to safe banking also made it harder for marijuana regulators to promote equity and safeguard public health as well as consumer safety, in addition to promoting regulatory certainty with regard to those involved in the industry. CANNRA then urged Congress to accord prominence to policy approaches that promoted safe banking. This comes as more legislators, including Rep. Earl Blumenauer and Sen. Patty Murray, call for the advancement of the SAFE Baking Act.

Plant-touching and non-plant-touching companies alike, such as Advanced Container Technologies Inc. (OTC: ACTX), may be following the proceedings in the bicameral conference closely since the report the conference submits could have far-reaching consequences for the cannabis industry.

NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Commissioner Califf Admits FDA Hasn’t Done Much on CBD

While addressing a Congressional panel, FDA chief Dr. Robert Califf admitted that the agency he heads hasn’t been as fast as stakeholders may want as it handles matters of creating regulatory pathways for different products, including cannabidiol, extracted from hemp. This is despite the legalization at a federal level of hemp as well as its derivatives several years ago.

He admitted that while things look the same as they were when hemp was legalized back in 2018, his agency now has more data because it has been doing plenty of research. He added that most of the funds allocated to the FDA on matters of CBD regulation had gone to studying potential risks associated with the use of the different forms of CBD and application methods.

Califf told the subcommittee of the House Appropriations Committee that even if he was prepared to move ahead with finding ways to regulate CBD, it would be better if Congress gave the FDA additional powers on the matter beyond what it currently has. As a way of explaining what he meant, the commissioner observed that the current powers the FDA had in regulating foods on the one hand and drugs on the other hand are inadequate for this situation and something totally different (a new framework) would be required to get the needed regulations in place.

The FDA commissioner faced a barrage of questions from lawmakers on both sides of the political divide expressing their frustration about the agency’s inaction, which has resulted in widespread confusion among manufacturers and consumers.

Early this month, Rep. James Comer, a ranking GOP member of the House Oversight & Reform Committee, penned a letter to the chair of the committee requesting a sitting dedicated to holding the U.S. Food and Drug Administration responsible for its failure to formulate the necessary regulations so that the CBD sector can be overseen by this agency.

Subcommittee members also probed the commissioner about his agency’s view about kratom. He said kratom has some worrying side effects, which was why the FDA had tightened import controls on this “controversial tree.” The members, including Rep. Mark Pocan, responded to his answers by saying NIDA had a different perspective on kratom and that the FDA should see what NIDA had on this plant.

Commenting about the responses of the FDA commissioner during the Thursday hearing, several cannabis advocacy groups were cautiously optimistic that Califf would steer the agency appropriately on matters of regulating CBD. For example, the U.S. Hemp Roundtable took some encouragement from Califf’s tone, which signaled that he was personally unhappy that nothing had been done to regulate CBD since hemp had become federally legal.

The entire cannabis sector would likely benefit if there were federal regulations creating markets that entities such as American Cannabis Partners could serve from one coast to the other.

NOTE TO INVESTORS: The latest news and updates relating to American Cannabis Partners are available in the company’s newsroom at https://cnw.fm/ACP

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – CannabisNewsWire to Heighten Visibility of Upcoming CWCBExpo

CannabisNewsWire (“CNW”), a specialized communications platform for the cannabis sector and one of the 50+ brands of IBN (“InvestorBrandNetwork”), today announced that it will be collaborating with the organizers of CWCBExpo (Cannabis World Congress & Business Exposition) in its capacity as the official newswire for the June event. The conference is slated to take place June 2-4, 2022, at New York City’s Javits Convention Center, Hall 3A. Having earned a reputation as a premier B2B cannabis, CBD and hemp event, the upcoming CWCBExpo will feature influential speakers, interactive “talk show” and educational sessions, innovative product displays and exclusive networking opportunities to explore the potential of the cannabis market. “It is a real pleasure to partner with CannabisNewsWire and IBN once again, and we look forward to collaborating in the future too,” said Christine Ianuzzi, managing partner and show director of CWCBExpo. “IBN has an extensive network of brands working within the cannabis, CBD and hemp industries. Their collective network will heighten visibility for our sponsors, speakers and conference participants.”

To view the full press release, visit https://cnw.fm/AwUkI

About CannabisNewsWire

CannabisNewsWire (“CNW”), one of 50+ brands within IBN (“InvestorBrandNetwork”), is a specialized information service that (1) aggregates cannabis news; (2) provides CannabisNewsBreaks to quickly update investors in the space; (3) enhances corporate press releases; (4) provides social media distribution via IBN to millions of social media followers; and (5) delivers comprehensive corporate communication solutions. CNW is uniquely positioned in the cannabis market with a strong team of journalists and writers who can help private and public companies reach a wide audience of investors, consumers, journalists and the general public through its ever-growing dissemination network of 5,000+ key syndication outlets. CNW is bringing unparalleled visibility, recognition and content to the cannabis industry.

For more information, please visit www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.